Brown Advisory Inc. Has $180.20 Million Holdings in Agilent Technologies, Inc. (NYSE:A)

Brown Advisory Inc. cut its position in Agilent Technologies, Inc. (NYSE:A - Free Report) by 51.2% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,540,442 shares of the medical research company's stock after selling 1,612,977 shares during the period. Brown Advisory Inc. owned about 0.54% of Agilent Technologies worth $180,201,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Redwood Park Advisors LLC acquired a new stake in shares of Agilent Technologies during the fourth quarter worth $27,000. Lee Danner & Bass Inc. acquired a new stake in shares of Agilent Technologies during the fourth quarter worth $29,000. Whipplewood Advisors LLC raised its holdings in shares of Agilent Technologies by 286.2% during the first quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock worth $29,000 after acquiring an additional 186 shares during the period. Sunbelt Securities Inc. raised its holdings in shares of Agilent Technologies by 640.0% during the fourth quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company's stock worth $30,000 after acquiring an additional 192 shares during the period. Finally, Opal Wealth Advisors LLC acquired a new stake in shares of Agilent Technologies during the first quarter worth $31,000.

Insider Activity

In other news, CEO Padraig Mcdonnell sold 1,508 shares of the firm's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total transaction of $177,099.52. Following the completion of the transaction, the chief executive officer owned 37,448 shares of the company's stock, valued at approximately $4,397,893.12. This trade represents a 3.87% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Agilent Technologies Price Performance

Shares of NYSE:A traded up $1.85 during midday trading on Tuesday, hitting $121.10. The stock had a trading volume of 1,917,044 shares, compared to its average volume of 1,845,257. The company's 50-day moving average price is $114.04 and its 200-day moving average price is $123.03. The company has a market capitalization of $34.40 billion, a P/E ratio of 29.90, a price-to-earnings-growth ratio of 3.68 and a beta of 1.23. The company has a quick ratio of 1.60, a current ratio of 2.09 and a debt-to-equity ratio of 0.55. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $153.84.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings data on Wednesday, May 28th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.26 by $0.05. The business had revenue of $1.67 billion during the quarter, compared to analysts' expectations of $1.63 billion. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. The firm's quarterly revenue was up 6.0% compared to the same quarter last year. During the same period in the prior year, the company earned $1.22 EPS. As a group, equities research analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 23rd. Stockholders of record on Tuesday, July 1st will be paid a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a dividend yield of 0.82%. The ex-dividend date is Tuesday, July 1st. Agilent Technologies's payout ratio is currently 24.44%.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. UBS Group lowered their price target on shares of Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating on the stock in a research note on Thursday, May 29th. Wells Fargo & Company lowered their price target on shares of Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating on the stock in a research note on Thursday, April 17th. Leerink Partners lifted their price target on shares of Agilent Technologies to $135.00 and gave the company a "buy" rating in a research note on Friday, May 30th. Jefferies Financial Group decreased their price objective on shares of Agilent Technologies from $135.00 to $116.00 and set a "hold" rating for the company in a research report on Monday, April 21st. Finally, Robert W. Baird decreased their price objective on shares of Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating for the company in a research report on Thursday, May 22nd. Six research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $139.77.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.